Bloomberg Technology

‘America First’ Trades Dominating Secondary Markets

PitchBook’s Senior Venture Capital Analyst Emily Zheng discusses where investments in the secondary markets are flowing. She joins Caroline Hyde on “Bloomberg Tech.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:   Get the latest in tech…

Published

on

PitchBook’s Senior Venture Capital Analyst Emily Zheng discusses where investments in the secondary markets are flowing. She joins Caroline Hyde on “Bloomberg Tech.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

8 Comments

  1. @BloqueadaFalk

    August 30, 2025 at 9:44 am

    The moment Avilom gets listed on top exchanges, $50–100 is the next zone.

  2. @MandeepAugustine

    August 30, 2025 at 9:44 am

    Avilom to $50 is just the beginning — this tech is undervalued at every level.

  3. @BetzyMiles

    August 30, 2025 at 9:44 am

    $100 Avilom isn’t a dream — it’s a matter of time and demand.

  4. @TroyGilbert-h4y

    August 30, 2025 at 9:45 am

    $2 Avilom is conservative, if adoption ramps up, $100+ is on the table.

  5. @BloqueadaFalk

    August 30, 2025 at 9:45 am

    $0.02 AVM today… $150 in 2 years, feels just like early MATIC.

  6. @AlannaMercado-v5r

    August 30, 2025 at 9:45 am

    In the next bull run, $100 AVM would make perfect sense.

  7. @KitKuntz

    August 30, 2025 at 9:45 am

    The Avilom chart will tell the story — $4 looks like the breakout point.

  8. @RichWainwright-p8f

    August 30, 2025 at 9:45 am

    At $50, Avilom would still be undervalued compared to Solana’s ATH.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version